Award
NIH Reporter #11258488
Anti-Complement Immunotherapy for Pancreatic Cancer
Recipient
Albert Einstein College of Medicine
Award Amount
$55,114.00
Ceiling
$55,114.00
Awarded
January 07, 2026
Identifier
11258488
Award for research on anti-complement immunotherapy for pancreatic cancer, including preclinical and translational studies, funded by NIH.
Description
NIH grant project focusing on understanding the role of complement activation in pancreatic ductal adenocarcinoma (PDAC) and exploring immunotherapeutic strategies involving complement blockade and radiotherapy. The project includes preclinical studies using mouse models, imaging, histology, flow cytometry, and translational research with antibodies and inhibitors.